Robust neutralizing antibody response to SARS-CoV-2 mRNA vaccination in adolescents and young adults with childhood-onset rheumatic diseases.

Rheumatology (Oxford, England)(2022)

引用 9|浏览15
暂无评分
摘要
SARS-CoV-2 mRNA vaccines were efficacious after the two-dose regimen in almost all AYA with cRD without serious adverse event. The rate of disease flare observed is 4.4% after the second mRNA vaccine dose.
更多
查看译文
关键词
COVID-19,SARS-CoV-2 vaccine,childhood-onset rheumatic disease,paediatric age,paediatric rheumatology,vaccine efficacy,vaccine safety
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要